Inserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000, Lyon, France.
Centre Léon Bérard, F-69008, Lyon, France.
Nat Commun. 2022 Jan 10;13(1):173. doi: 10.1038/s41467-021-27847-8.
Mechanisms of drug-tolerance remain poorly understood and have been linked to genomic but also to non-genomic processes. 5-fluorouracil (5-FU), the most widely used chemotherapy in oncology is associated with resistance. While prescribed as an inhibitor of DNA replication, 5-FU alters all RNA pathways. Here, we show that 5-FU treatment leads to the production of fluorinated ribosomes exhibiting altered translational activities. 5-FU is incorporated into ribosomal RNAs of mature ribosomes in cancer cell lines, colorectal xenografts, and human tumors. Fluorinated ribosomes appear to be functional, yet, they display a selective translational activity towards mRNAs depending on the nature of their 5'-untranslated region. As a result, we find that sustained translation of IGF-1R mRNA, which encodes one of the most potent cell survival effectors, promotes the survival of 5-FU-treated colorectal cancer cells. Altogether, our results demonstrate that "man-made" fluorinated ribosomes favor the drug-tolerant cellular phenotype by promoting translation of survival genes.
药物耐受的机制仍未得到很好的理解,与基因组和非基因组过程都有关系。5-氟尿嘧啶(5-FU)是肿瘤学中最广泛使用的化疗药物,与耐药性有关。虽然被规定为 DNA 复制的抑制剂,但 5-FU 会改变所有的 RNA 途径。在这里,我们表明 5-FU 处理会导致产生具有改变翻译活性的氟化核糖体。5-FU 被掺入癌细胞系、结直肠异种移植和人类肿瘤中成熟核糖体的核糖体 RNA 中。氟化核糖体似乎具有功能,但它们根据其 5'-非翻译区的性质,对 mRNA 表现出选择性的翻译活性。结果,我们发现 IGF-1R mRNA 的持续翻译,该基因编码一种最有效的细胞存活效应因子,促进了 5-FU 处理的结直肠癌细胞的存活。总之,我们的结果表明,“人造”氟化核糖体通过促进存活基因的翻译,促进了具有药物耐受表型的细胞。